Spire Wealth Management - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q1 2022$7,000
-22.2%
4,0000.0%0.00%
Q4 2021$9,000
-30.8%
4,0000.0%0.00%
Q3 2021$13,000
+18.2%
4,0000.0%0.00%
Q2 2021$11,000
+22.2%
4,0000.0%0.00%
Q1 2021$9,0004,0000.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q3 2021
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders